Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS).
Cancers (Basel). 2022 May 31;14(11):2733. doi: 10.3390/cancers14112733.
Cancers (Basel). 2022.
PMID: 35681712
Free PMC article.
Chromenopyrimidinone Controls Stemness and Malignancy by suppressing CD133 Expression in Hepatocellular Carcinoma.
Song Y, Kim S, Lee H, No JH, Ryu HC, Kim J, Lim JW, Kim M, Choi I, Seo HR.
Song Y, et al.
Cancers (Basel). 2020 May 8;12(5):1193. doi: 10.3390/cancers12051193.
Cancers (Basel). 2020.
PMID: 32397206
Free PMC article.
Item in Clipboard
GSK-3β regulates the endothelial-to-mesenchymal transition via reciprocal crosstalk between NSCLC cells and HUVECs in multicellular tumor spheroid models.
Kim SH, Song Y, Seo HR.
Kim SH, et al.
J Exp Clin Cancer Res. 2019 Feb 1;38(1):46. doi: 10.1186/s13046-019-1050-1.
J Exp Clin Cancer Res. 2019.
PMID: 30709379
Free PMC article.
Item in Clipboard
Cite
Cite